This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
2.F Islami , Alcohol drinking and esophageal squamous cell carcinoma with focus on light-drinkers and never-smokers: a systematic review and meta-analysis. International journal of cancer 2011; 129: 2473–2484.
3.RS Holmes , TL Vaughan . Epidemiology and pathogenesis of esophageal cancer. Seminars in Radiation Oncology 2007; 17: 2–9.
6.A Ciapponi , Type-specific HPV prevalence in cervical cancer and high-grade lesions in Latin America and the Caribbean: systematic review and meta-analysis. PLoS ONE 2011; 6: e25493.
7.AR Kreimer , Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiology, Biomarkers & Prevention 2005; 14: 467–475.
8.MK Stelzer , A mouse model for human anal cancer. Cancer Prevention Research (Philadelphia, PA) 2010; 3: 1534–1541.
10.JS Koh , No association of high-risk human papillomavirus with esophageal squamous cell carcinomas among Koreans, as determined by polymerase chain reaction. Diseases of the Esophagus 2008; 21: 114–117.
11.T Li , Human papillomavirus type 16 is an important infectious factor in the high incidence of esophageal cancer in Anyang area of China. Carcinogenesis 2001; 22: 929–934.
12.EM de Villiers , Classification of papillomaviruses. Virology 2004; 324: 17–27.
13.SK Zhang , Prevalence of human papillomavirus 16 in esophageal cancer among the Chinese population: a systematic review and meta-analysis. Asian Pacific Journal of Cancer Prevention 2014; 15: 10143–10149.
14.KJ Syrjanen . HPV infections and oesophageal cancer. Journal of Clinical Pathology 2002; 55: 721–728.
15.JL Petrick , Prevalence of human papillomavirus among oesophageal squamous cell carcinoma cases: systematic review and meta-analysis. British Journal of Cancer 2014; 110: 2369–2377.
16.JJ Barendregt , Meta-analysis of prevalence. Journal of Epidemiology and Community Health 2013; 67: 974–978.
. Meta-analysis in clinical trials. Controlled Clinical Trials
1986; 7: 177–188.
18.JPT Higgins , SG Thompson . Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002; 21: 1539–1558.
21.X Wang , Detection of HPV DNA in esophageal cancer specimens from different regions and ethnic groups: a descriptive study. BMC Cancer 2010; 10: 19.
26.X Cui , Heterozygote of PLCE1 rs2274223 increases susceptibility to human papillomavirus infection in patients with esophageal carcinoma among the Kazakh populations. Journal of Medical Virology 2014; 86: 608–617.
27.XM Lu , Human papillomavirus in esophageal squamous cell carcinoma of the high-risk Kazakh ethnic group in Xinjiang, China. European Journal of Surgical Oncology 2008; 34: 765–770.
28.K Shuyama , Human papillomavirus in high- and low-risk areas of oesophageal squamous cell carcinoma in China. British Journal of Cancer 2007; 96: 1554–1559.
29.M Dai , Human papillomavirus infection among 100 oesophageal cancer cases in the People's Republic of China. International Journal of Cancer 2007; 121: 1396–1398.
30.F Guo , Human papillomavirus infection and esophageal squamous cell carcinoma: a case-control study. Cancer Epidemiology, Biomarkers & Prevention 2012; 21: 780–785.
31.QY Zhang , Infection and integration of human papillomavirus in esophageal carcinoma. International Journal of Hygiene and Environmental Health 2011; 214: 156–161.
32.B Cao , LMP7/TAP2 gene polymorphisms and HPV infection in esophageal carcinoma patients from a high incidence area in China. Carcinogenesis 2005; 26: 1280–1284.
33.J Koshiol , No role for human papillomavirus in esophageal squamous cell carcinoma in China. International Journal of Cancer 2010; 127: 93–100.
34.HY Liu , Prevalence of human papillomavirus infection in esophageal and cervical cancers in the high incidence area for the two diseases from 2007 to 2009 in Linzhou of Henan Province, Northern China. Archives of Virology 2014; 159: 1393–1401.
37.T Liu , Viral load of HPV 16/18 in esophageal squamous cell carcinoma in three ethnic groups living in Xinjiang Autonomous Region, China. Molecular Biology Reports 2013; 40: 2045–2052.
38.GM Clifford , Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. British Journal of Cancer 2003; 88: 63–73.
39.MI Rosa , The prevalence of human papillomavirus in ovarian cancer: a systematic review. International Journal of Gynecological Cancer 2013; 23: 437–441.
40.X Li , Human papillomavirus infection and laryngeal cancer risk: a systematic review and meta-analysis. Journal of Infectious Diseases 2013; 207: 479–488.
41.N Li , Human papillomavirus infection and bladder cancer risk: a meta-analysis. Journal of Infectious Diseases 2011; 204: 217–223.
42.M Srinivasan , E Taioli , CC Ragin . Human papillomavirus type 16 and 18 in primary lung cancers–a meta-analysis. Carcinogenesis 2009; 30: 1722–1728.
43.F Kamangar , Human papillomavirus serology and the risk of esophageal and gastric cancers: results from a cohort in a high-risk region in China. International Journal of Cancer 2006; 119: 579–584.
44.M Poljak , A Cerar , K Seme . Human papillomavirus infection in esophageal carcinomas: a study of 121 lesions using multiple broad-spectrum polymerase chain reactions and literature review. Human Pathology 1998; 29: 266–271.
46.S Garcia-Vallve , A Alonso , IG Bravo . Papillomaviruses: different genes have different histories. Trends in Microbiology 2005; 13: 514–521.
47.K Munger , PM Howley . Human papillomavirus immortalization and transformation functions. Virus Research 2002; 89: 213–228.
48.CM Hebner , LA Laimins . Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Reviews in Medical Virology 2006; 16: 83–97.